Volume 100, Issue 12

Search all Annals of Hematology articles

December 2021

33 articles in this issue

Targeted therapies for immune thrombocytopenic purpura: a meta-analysis of randomized controlled trials
Inbar Cohen
Hadar Goldvaser
Daniel Shepshelovich
Review Article 06 October 2021 Pages: 2879 - 2887
The optimal timing of radiotherapy in the combination treatment of limited-stage extranodal natural killer/T-cell lymphoma, nasal type: an updated meta-analysis
Yue Cui
Yuyi Yao
Quanguang Ren
Review Article 27 October 2021 Pages: 2889 - 2900
Long-term safety and efficacy of hydroxyurea in patients with non-transfusion-dependent β-thalassemia: a comprehensive single-center experience
Mehran Karimi
Tahereh Zarei
Sezaneh Haghpanah
Original Article 12 August 2021 Pages: 2901 - 2907
Circulating miRNAs and tissue iron overload in transfusion-dependent β-thalassemia major: novel predictors and follow-up guide
Nashwa El-Khazragy
Safa Matbouly
Soha Abuelela
Original Article 25 August 2021 Pages: 2909 - 2917
Correction to: Circulating miRNAs and tissue iron overload in transfusion-dependent β-thalassemia major: novel predictors and follow-up guide
Nashwa El-Khazragy
Safa Matbouly
Soha Abuelela
Correction 06 October 2021 Pages: 2919 - 2919
The anemia-independent impact of myelodysplastic syndromes on health-related quality of life
Hanneke J. C. M. Wouters
Annette Conrads-Frank
on behalf of the MDS-RIGHT partners
Original Article Open access 02 September 2021 Pages: 2921 - 2932
The BET bromodomain inhibitor ZEN-3365 targets the Hedgehog signaling pathway in acute myeloid leukemia
Jasmin Wellbrock
Lena Behrmann
Walter Fiedler
Original Article Open access 01 August 2021 Pages: 2933 - 2941
Early and late stage MPN patients show distinct gene expression profiles in CD34⁺ cells
Julian Baumeister
Tiago Maié
Deniz Gezer
Original Article Open access 14 August 2021 Pages: 2943 - 2956
Phase II study of single-agent nivolumab in patients with myelofibrosis
Iman Abou Dalle
Hagop Kantarjian
Srdan Verstovsek
Original Article 05 August 2021 Pages: 2957 - 2960
Bortezomib in combination with fludarabine plus cyclophosphamide for patients with relapsed or refractory mantle-cell lymphoma: results of the LYM-4003 study
Xiao-Xiao Wang
Yan Gao
on behalf of the Lymphoma Committee, Chinese Anti-Cancer Association (CACA)
Original Article 31 July 2021 Pages: 2961 - 2968
Combination of novel molecular targeted agent plus R-CHOP-based regimen versus R-CHOP alone in previously untreated diffuse large B-cell lymphoma (DLBCL) patients: a systematic review and meta-analysis.
Guillermo Villacampa
Rodrigo Dienstmann
Pau Abrisqueta
Original Article 10 August 2021 Pages: 2969 - 2978
Bone marrow tracer uptake pattern of PET-CT in multiple myeloma: image interpretation and prognostic value
Jing Li
Hui Tan
Peng Liu
Original Article 20 August 2021 Pages: 2979 - 2988
Minimal residual disease detection in multiple myeloma: comparison between BML single-tube 10-color multiparameter flow cytometry and EuroFlow multiparameter flow cytometry
Kota Sato
Kiyoshi Okazuka
Kenshi Suzuki
Original Article 25 August 2021 Pages: 2989 - 2995
Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease
Ignacio Isola
David F. Moreno
Carlos Fernández de Larrea
Original Article 31 August 2021 Pages: 2997 - 3005
Prevalence of hypogammaglobulinemia and its management with subcutaneous immunoglobulin supplementation in patients after allogeneic hematopoietic stem cell transplantation—a single-center analysis
Ewa Karakulska-Prystupiuk
Jadwiga Dwilewicz-Trojaczek
Wiesław Wiktor Jędrzejczak
Original Article Open access 03 September 2021 Pages: 3007 - 3016
The differential effect of disease status at allogeneic hematopoietic cell transplantation on outcomes in acute myeloid and lymphoblastic leukemia
Masamitsu Yanada
Takaaki Konuma
Shingo Yano
Original Article 03 September 2021 Pages: 3017 - 3027
Cytomegalovirus reactivation is associated with an increased risk of late-onset invasive aspergillosis independently of grade II–IV acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: JSTCT Transplant Complications Working Group
Shun-ichi Kimura
Masaharu Tamaki
Hideki Nakasone
Original Article 07 September 2021 Pages: 3029 - 3038
Successful outcome of anaplastic multiple myeloma with lenalidomide, cyclophosphamide, and dexamethasone therapy
Wenjiao Tang
Yangfan Xu
Bing Xiang
Letter to the Editor 02 September 2020 Pages: 3039 - 3040
Stem cell transplantation for hemoglobinopathy Vila Real
Justin Hasenkamp
Joachim Riggert
Gerald Wulf
Letter to the Editor Open access 03 September 2020 Pages: 3041 - 3042
Coexistence of MYC/BCL2 double-hit of t(8;14)(q24;q32) and t(14;18)(q32;q21) and that of t(8;22)(q24;q11) and t(14;18) in advanced-stage high-grade B cell lymphoma
Kayo Takeoka
Miho Nakagawa
Hitoshi Ohno
Letter to the Editor 07 September 2020 Pages: 3043 - 3045
Circulating blastoid cells: acute leukemia, prolymphocytic leukemia, or something else?
Yue Zhao
Catherine Rehder
Endi Wang
Letter to the Editor 15 September 2020 Pages: 3047 - 3048
Temozolomide showed rapid activity in a patient with refractory CNS monomorphic epitheliotropic T cell lymphoma
Pui-Lun Yip
Ching-Pong Lam
Sze-Man June Lau
Letter to the Editor 25 September 2020 Pages: 3049 - 3050
Caplacizumab: frequent local skin reactions
Jessica Kaufeld
Paul T. Brinkkoetter
Linus A. Völker
Letter to the Editor Open access 30 September 2020 Pages: 3051 - 3052
Successful treatment with enasidenib, bortezomib, and dexamethasone for the synchronous occurrence of IDH2-positive acute myeloid leukemia and multiple myeloma
Donald C. Moore
Viera Nelson
Alaa Muslimani
Letter to the Editor 01 October 2020 Pages: 3053 - 3055
Selinexor, bortezomib, and dexamethasone (SVD) in heavily treated relapsed refractory multiple myeloma
Tarek H. Mouhieddine
Samir Parekh
Deepu Madduri
Letter to the Editor 02 October 2020 Pages: 3057 - 3060
EBV+ posttransplant lymphoproliferative disease of the retina presenting as cytomegalovirus retinitis
Ian Y. Wong
Wing-Lau Ho
Yok-Lam Kwong
Letter to the Editor 03 October 2020 Pages: 3061 - 3063
Cutaneous botryomycosis mimicking ecthyma gangrenosum in a patient treated with ibrutinib
Ana Pulido-Pérez
Marta Bergón-Sendín
Fernando Carretero-López
Letter to the Editor 07 October 2020 Pages: 3065 - 3066
Successful myeloablative unrelated bone marrow transplantation for relapsed intravascular large B cell lymphoma after autologous peripheral blood stem cell transplantation
Yoko Miura
Jun Ooi
Naoki Shirafuji
Letter to the Editor 22 October 2020 Pages: 3067 - 3069
Plasma cell myeloma with pure lymphocyte-like morphology
Kyoungyul Lee
Sook Won Ryu
Jin Ho Paik
Letter to the Editor 02 November 2020 Pages: 3071 - 3073
Clonal IgH gene rearrangements identify Richter’s transformation to diffuse large B cell lymphoma
Disha Dalela
Jacob R. Bledsoe
Shyam A. Patel
Letter to the Editor 07 November 2020 Pages: 3075 - 3077
Cutaneous marginal zone lymphoma following anthrax vaccination
Jocelyn B. Chandler
Reid Waldman
Ellice Y. Wong
Letter to the Editor 16 November 2020 Pages: 3079 - 3080
Questioning the association between ABO type and outcomes in patients with COVID-19
Jori E. May
Gerald McGwin Jr
Marisa B. Marques
Letter to the Editor 17 November 2020 Pages: 3081 - 3082
Correction to: Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab
Ka-Won Kang
Hyemi Moon
Yong Park
Correction 07 October 2021 Pages: 3083 - 3083

Volume 100, Issue 12

Targeted therapies for immune thrombocytopenic purpura: a meta-analysis of randomized controlled trials

The optimal timing of radiotherapy in the combination treatment of limited-stage extranodal natural killer/T-cell lymphoma, nasal type: an updated meta-analysis

Long-term safety and efficacy of hydroxyurea in patients with non-transfusion-dependent β-thalassemia: a comprehensive single-center experience

Circulating miRNAs and tissue iron overload in transfusion-dependent β-thalassemia major: novel predictors and follow-up guide

Correction to: Circulating miRNAs and tissue iron overload in transfusion-dependent β-thalassemia major: novel predictors and follow-up guide

The anemia-independent impact of myelodysplastic syndromes on health-related quality of life

The BET bromodomain inhibitor ZEN-3365 targets the Hedgehog signaling pathway in acute myeloid leukemia

Early and late stage MPN patients show distinct gene expression profiles in CD34⁺ cells

Phase II study of single-agent nivolumab in patients with myelofibrosis

Bortezomib in combination with fludarabine plus cyclophosphamide for patients with relapsed or refractory mantle-cell lymphoma: results of the LYM-4003 study

Combination of novel molecular targeted agent plus R-CHOP-based regimen versus R-CHOP alone in previously untreated diffuse large B-cell lymphoma (DLBCL) patients: a systematic review and meta-analysis.

Bone marrow tracer uptake pattern of PET-CT in multiple myeloma: image interpretation and prognostic value

Minimal residual disease detection in multiple myeloma: comparison between BML single-tube 10-color multiparameter flow cytometry and EuroFlow multiparameter flow cytometry

Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease

Prevalence of hypogammaglobulinemia and its management with subcutaneous immunoglobulin supplementation in patients after allogeneic hematopoietic stem cell transplantation—a single-center analysis

The differential effect of disease status at allogeneic hematopoietic cell transplantation on outcomes in acute myeloid and lymphoblastic leukemia

Cytomegalovirus reactivation is associated with an increased risk of late-onset invasive aspergillosis independently of grade II–IV acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: JSTCT Transplant Complications Working Group

Successful outcome of anaplastic multiple myeloma with lenalidomide, cyclophosphamide, and dexamethasone therapy

Stem cell transplantation for hemoglobinopathy Vila Real

Coexistence of MYC/BCL2 double-hit of t(8;14)(q24;q32) and t(14;18)(q32;q21) and that of t(8;22)(q24;q11) and t(14;18) in advanced-stage high-grade B cell lymphoma

Circulating blastoid cells: acute leukemia, prolymphocytic leukemia, or something else?

Temozolomide showed rapid activity in a patient with refractory CNS monomorphic epitheliotropic T cell lymphoma

Caplacizumab: frequent local skin reactions

Successful treatment with enasidenib, bortezomib, and dexamethasone for the synchronous occurrence of IDH2-positive acute myeloid leukemia and multiple myeloma

Selinexor, bortezomib, and dexamethasone (SVD) in heavily treated relapsed refractory multiple myeloma

EBV+ posttransplant lymphoproliferative disease of the retina presenting as cytomegalovirus retinitis

Cutaneous botryomycosis mimicking ecthyma gangrenosum in a patient treated with ibrutinib

Successful myeloablative unrelated bone marrow transplantation for relapsed intravascular large B cell lymphoma after autologous peripheral blood stem cell transplantation

Plasma cell myeloma with pure lymphocyte-like morphology

Clonal IgH gene rearrangements identify Richter’s transformation to diffuse large B cell lymphoma

Cutaneous marginal zone lymphoma following anthrax vaccination

Questioning the association between ABO type and outcomes in patients with COVID-19

Correction to: Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab

Navigation